120
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Cefazolin Plus Ceftazidime versus Cefazolin Monotherapy in the Treatment of Culture-Negative Peritonitis: A Retrospective Cohort Study

, , , , , & ORCID Icon show all
Pages 17-25 | Published online: 11 Feb 2022

References

  • Szeto CC, Li PK. Peritoneal dialysis-associated peritonitis. Clin J Am Soc Nephrol. 2019;14(7):1100–1105. doi:10.2215/CJN.14631218
  • Boudville N, Kemp A, Clayton P, et al. Recent peritonitis associates with mortality among patients treated with peritoneal dialysis. J Am Soc Nephrol. 2012;23(8):1398–1405. doi:10.1681/ASN.2011121135
  • Perl J, Fuller DS, Bieber BA, et al. Peritoneal dialysis-related infection rates and outcomes: results from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS). Am J Kidney Dis. 2020;76(1):42–53. doi:10.1053/j.ajkd.2019.09.016
  • Fahim M, Hawley CM, McDonald SP, et al. Culture-negative peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes in 435 cases. Am J Kidney Dis. 2010;55(4):690–697. doi:10.1053/j.ajkd.2009.11.015
  • Li PK, Szeto CC, Piraino B, et al. ISPD peritonitis recommendations: 2016 update on prevention and treatment. Perit Dial Int. 2016;36(5):481–508. doi:10.3747/pdi.2016.00078
  • Boudville N, Johnson DW, Zhao J, et al. Regional variation in the treatment and prevention of peritoneal dialysis-related infections in the Peritoneal Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant. 2019;34(12):2118–2126. doi:10.1093/ndt/gfy204
  • Li PK, Szeto CC, Piraino B, et al. Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int. 2010;30(4):393–423. doi:10.3747/pdi.2010.00049
  • Htay H, Cho Y, Pascoe EM, et al. Multicentre registry data analysis comparing outcomes of culture-negative peritonitis and different subtypes of culture-positive peritonitis in peritoneal dialysis patients. Perit Dial Int. 2020;40(1):47–56. doi:10.1177/0896860819879891
  • Chen KH, Chang CT, Weng SM, et al. Culture-negative peritonitis: a fifteen-year review. Ren Fail. 2007;29(2):177–181. doi:10.1080/08860220601098847
  • Zhou Q, Bajo MA, Del Peso G, Yu X, Selgas R. Preventing peritoneal membrane fibrosis in peritoneal dialysis patients. Kidney Int. 2016;90(3):515–524. doi:10.1016/j.kint.2016.03.040
  • Davies SJ. Peritoneal solute transport and inflammation. Am J Kidney Dis. 2014;64(6):978–986. doi:10.1053/j.ajkd.2014.06.030
  • Szeto CC, Wong TY, Chow KM, Leung CB, Li PK. The clinical course of culture-negative peritonitis complicating peritoneal dialysis. Am J Kidney Dis. 2003;42(3):567–574. doi:10.1016/S0272-6386(03)00790-X
  • Kocyigit I, Unal A, Karademir D, et al. Improvement in culture-negative peritoneal dialysis-related peritonitis: a single center’s experience. Perit Dial Int. 2012;32(4):476–478. doi:10.3747/pdi.2011.00153
  • Chow KM, Szeto CC, Cheung KK, et al. Predictive value of dialysate cell counts in peritonitis complicating peritoneal dialysis. Clin J Am Soc Nephrol. 2006;1(4):768–773. doi:10.2215/CJN.01010306
  • Chuang YW, Shu KH, Yu TM, Cheng CH, Chen CH. Hypokalaemia: an independent risk factor of Enterobacteriaceae peritonitis in CAPD patients. Nephrol Dial Transplant. 2009;24(5):1603–1608. doi:10.1093/ndt/gfn709
  • Ribeiro SC, Figueiredo AE, Barretti P, Pecoits-Filho R, de Moraes TP, Aguilera AI; All centers that contributed to BIIs. Low serum potassium levels increase the infectious-caused mortality in peritoneal dialysis patients: a Propensity-Matched Score Study. PLoS One. 2015;10(6):e0127453. doi:10.1371/journal.pone.0127453
  • Shu KH, Chang CS, Chuang YW, et al. Intestinal bacterial overgrowth in CAPD patients with hypokalaemia. Nephrol Dial Transplant. 2009;24(4):1289–1292. doi:10.1093/ndt/gfn617
  • Ma X, Shi Y, Tao M, et al. Analysis of risk factors and outcome in peritoneal dialysis patients with early-onset peritonitis: a multicentre, retrospective cohort study. BMJ Open. 2020;10(2):e029949. doi:10.1136/bmjopen-2019-029949